February 25, 2025 A Framework to Standardize Gait Study Protocols in Parkinson’s Disease Research over the past twenty years has shown that gait outcomes have a high sensitivity for diagnosing Parkinson's disease (PD)..
February 1, 2025 Understanding what aspects of Parkinson’s disease matter most to patients and families Understanding what matters to people with Parkinson’s and their family is essential to derive relevant clinical outcome measures
February 1, 2025 Accelerating Parkinson’s Disease Drug Development with Federated Learning Approaches Parkinson’s Disease is a progressive neurodegenerative disorder afflicting almost 12 million people...
February 24, 2025 Lysosomal Storage Disease Data Sharing Workshop, Webinar Series – Session #1: Setting the Scene C-Path's CPLD team presents, "Lysosomal Storage Disease Data Sharing Workshop, Webinar Series - Session #1...
February 20, 2025 Living with Young Onset Parkinson’s Disease: PD Community Advocate Sarah Zenner-Dolan’s Joins C-Path’s 20th Anniversary Celebration Critical Path for Parkinson's Consortium (CPP) Advisor and FDA Advisory Committee Member Sarah Zenner-Dolan...
February 19, 2025 Advancing Neonatal Drug Development Through Collaboration At C-Path’s INC, we believe that meaningful progress in neonatal drug development...
February 19, 2025 C-Path’s eCOA Consortium Welcomes Veeva Systems and VPG Health as Newest Partners C-Path's eCOA Consortium is thrilled to welcome Veeva Systems and VPG Health...
February 18, 2025 C-Path’s CPA-1 Consortium Welcomes Newest Members Kamada, Sanofi Critical Path for Alpha-1 (CPA-1) consortium today announced the addition of biopharmaceutical companies, Kamada and Sanofi.
February 13, 2025 Breaking the silence: challenges and opportunities in pediatric drug development Pediatric drug development faces significant challenges, including underfunding, ethical concerns, and complex regulatory...
February 1, 2025 Increased discoverability of rare disease datasets through knowledge graph integration Healthcare datasets can be used for many different purposes in the pursuit of...